ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.

September 28, 2001

ASCO Begins Practice Certification Program

June 5, 2009

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

ACS Cancer Control Research Grant Programs Available

May 5, 2000

IOM appoints 22 to National Cancer Policy Forum.

July 1, 2005

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008